FEASIBILITY The upfront investment of time and medical expertise into each feasibility assessment underlies PSIs consistent enrollment success in clinical trials in an industry where 94% of trials fall behind schedule due to poor enrollment. For the majority of studies, where competition for patients and complexity of design are leading characteristics, we apply our years of experience to determine the best sites and countries for each study. We give every project a thorough assessment through our dedicated, full-time Feasibility Department. Our dedicated professionals determine clinical trial feasibility for each of the following criterion: Medical Feasibility Clinical Feasibility Logistical Feasibility Regulatory Feasibility With people located in 11 countries of North America, Europe, Asia and Latin America and led by our team of internal medical doctors, laboratory experts, imaging specialists, logisticians, pharmacy and regulatory experts, PSI predicts accurate dates for the enrollment of the ďŹ rst and last patients. In recent years, our specialists have conducted over 2,000+ feasibility assessments for studies in 50+ countries. These assessments cover, but are not restricted to, evaluation of the target population availability and factors that limit it, standards of care, competitive studies, regulatory climates and the need to engage particular Key Opinion Leaders into the study. We weigh all of these factors before making recommendations. Our value-added feasibility assessments for regional or global programs provide our sponsors with the best choice of sites & geography, ensuring predictable and accurate enrollment projections.
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.